ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L04AA" (109)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Antilymphocyte Immunoglobulin (Horse) (L04AA03) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SAtgam 250 mg/5 ml5 x 5 ml2797.163058.5010 %Concentrate for infusion: Immunoglobulinum Anti-T Limphocytorum ex Equus 50 mgPfizer AGA / SLG
Antithymocyte Immunoglobulin (Rabbit) (L04AA04) 4 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP V/SGRAFALONDurchstechflasche(n)372.42421.4510 %Concentrate for infusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 20 mg/mlNeovii
Pharmaceuticals AG		B / SLG
L IP V/SGRAFALON10 Durchstechflasche(n)3718.424060.4010 %Concentrate for infusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 20 mg/mlNeovii
Pharmaceuticals AG		B / SLG
  IP V/SThymoglobulineDurchstechflasche(n)k.A.poudre pour solution à diluer pour perfusion: Immunoglobulinum Anti-T Limphocytorum ex Cuniculus 25 mgSanofi-Aventis
(Suisse) SA		BG
  IP  Atgam5 x 5 ml2005.60k.A.Injection solution: Immunoglobulinum Antithymocyticum Equi 250 mgPharmacia AGBG
Mycophenolic Acid (L04AA06) 41 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI Cellcept 500 mg - T50 Tablet(s)90.85115.2020 %Coated tablets: Mofetili Mycophenolas 500 mgRoche Pharma
(Schweiz) AG		B / SL / SOG
  IPCI Cellcept 500 mg - T150272.56308.6520 %Coated tablets: Mofetili Mycophenolas 500 mgRoche Pharma
(Schweiz) AG		B / SL / SOG
  IPCI Cellcept 250 mg100 Capsule(s)99.23124.3520 %Capsules: Mofetili Mycophenolas 250 mgRoche Pharma
(Schweiz) AG		B / SL / SOG
  IPCI Cellcept 250 mg300297.69335.6020 %Capsules: Mofetili Mycophenolas 250 mgRoche Pharma
(Schweiz) AG		B / SL / SOG
  IPCI Mycophenolat-Mofetil
Sandoz 500 mg		150 Tablet(s)204.42238.7510 %Coated tablets: Mofetili Mycophenolas 500 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Myfenax 500 mg3 x 50204.42238.7510 %Coated tablets: Mofetili Mycophenolas 500 mgTeva Pharma AGB / SL / SGG
  IPCI Mycophenolat-Mofetil
Sandoz		300 Capsule(s)223.27259.2510 %Capsules: Mofetili Mycophenolas 250 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Myfenax 250 mg3 x 100223.28259.2510 %Capsules: Mofetili Mycophenolas 250 mgTeva Pharma AGB / SL / SGG
L IPCI CellceptFlasche(n) à 35 g148.18177.5510 %Pulver zur Herstellung einer Suspension zum Einnehmen: Mofetili Mycophenolas 200 mgRoche Pharma
(Schweiz) AG		B / SLG
  IPCI Myfortic 180 mg120 Tablet(s)125.48152.9010 %magensaftresistente Filmtabletten: Acidum Mycophenolicum 180 mgNovartis Pharma
Schweiz AG		B / SLG
  IPCI Myfortic 360 mg120 Tablet(s)229.66266.2010 %magensaftresistente Filmtabletten: Acidum Mycophenolicum 360 mgNovartis Pharma
Schweiz AG		B / SLG
  IPCI Cellcept i.v.4 Durchstechflasche(n)184.30k.A.Lyophilisate: Mofetili Mycophenolas 500 mgRoche Pharma
(Schweiz) AG		BG
  IPCI Cellcept 500 mg - T150371.07442.40k.A.Coated tablets: Mofetili Mycophenolas 500 mgRoche Pharma
(Schweiz) AG		BG
  IPCI Cellcept 250 mg300405.28481.65k.A.Capsules: Mofetili Mycophenolas 250 mgRoche Pharma
(Schweiz) AG		BG
  IPCI Cellcept 500 mg5074.9697.9510 %Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		B / SL / SOG
  IP  CellCept 500 mg5077.22100.4010 %Coated tablets: Mofetili Mycophenolas 500 mgEurimPharm Swiss AGB / SL / SOG
  IPCI Cellcept 500 mg150224.86259.7010 %Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		B / SL / SOG
  IPCI Cellcept 500 mg150224.86259.7010 %Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		B / SL / SOG
  IP  CellCept 500 mg3 x 50231.68266.7010 %Coated tablets: Mofetili Mycophenolas 500 mgEurimPharm Swiss AGB / SL / SOG
  IPCI Cellcept 250 mg10081.88105.4510 %Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		B / SL / SOG
  IPCI Cellcept 250 mg300245.59282.1510 %Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		B / SL / SOG
  IPCI Cellcept 250 mg300245.59282.1510 %Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		B / SL / SOG
  IPCI Cellcept 500 mg50k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg50k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg50k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IP  CellCept 500 mg150k.A.Coated tablets: Mofetili Mycophenolas 500 mgEurimPharm Swiss AGBG
  IPCI Cellcept 250 mg100k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg100k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg100k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg300k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg300k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg300k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg300k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg300k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
  IPCI Cellcept 250 mg300k.A.Capsules: Mofetili Mycophenolas 250 mgAPS-Arzneimittel-
Parallelimport-
Service AG		BG
Leflunomide (L04AA13) 9 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI Arava 10 mg ‐ I30 Tablet(s)11.8129.2010 %Coated tablets: Leflunomidum 10 mgSanofi-Aventis
(Suisse) SA		A / SL / SOG
  IPCI Arava 10 mg ‐ I100 Tablet(s)39.3759.0510 %Coated tablets: Leflunomidum 10 mgSanofi-Aventis
(Suisse) SA		A / SL / SOG
  IPCI Arava 20 mg30 Tablet(s)20.7138.8510 %Coated tablets: Leflunomidum 20 mgSanofi-Aventis
(Suisse) SA		A / SL / SOG
  IPCI Arava 20 mg100 Tablet(s)69.0491.2010 %Coated tablets: Leflunomidum 20 mgSanofi-Aventis
(Suisse) SA		A / SL / SOG
  IPCI Leflunomide Zentiva 10 mg30 Tablet(s)10.7528.1010 %Coated tablets: Leflunomidum 10 mgHelvepharm AG● A / SL / SGG
  IPCI Leflunomide Zentiva 10 mg100 Tablet(s)35.8355.4010 %Coated tablets: Leflunomidum 10 mgHelvepharm AGA / SL / SGG
  IPCI Leflunomide Zentiva 20 mg30 Tablet(s)18.8336.9010 %Coated tablets: Leflunomidum 20 mgHelvepharm AG● A / SL / SGG
  IPCI Leflunomide Zentiva 20 mg100 Tablet(s)62.7784.7510 %Coated tablets: Leflunomidum 20 mgHelvepharm AGA / SL / SGG
  IPCI Arava 100 mg3 Tablet(s)12.5529.95k.A.Coated tablets: Leflunomidum 100 mgSanofi-Aventis
(Suisse) SA		AG
Everolimus (L04AA18) 5 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
  IPCI Certican 0.1 mg60 Tablet(s)58.2679.8010 %Dispersible Tablets: EverolimusumNovartis Pharma
Schweiz AG		B / SLG
  IPCI Certican 0.25 mg60 Tablet(s)145.64174.8010 %Tablets: EverolimusumNovartis Pharma
Schweiz AG		B / SLG
  IPCI Certican 0.5 mg60 Tablet(s)291.27333.2010 %Tablets: EverolimusumNovartis Pharma
Schweiz AG		B / SLG
  IPCI Certican 0.75 mg60 Tablet(s)436.91491.6010 %Tablets: EverolimusumNovartis Pharma
Schweiz AG		B / SLG
  IPCI Certican 1 mg60 Tablet(s)582.55649.9510 %Tablets: Everolimusum 1 mgNovartis Pharma
Schweiz AG		B / SLG
Abatacept (L04AA24) 3 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Orencia 125 mg/1 ml4945.541044.7510 %Injektionslösung zur subkutanen Anwendung (Fertigpen): Abataceptum 125 mg/mlBristol-Myers Squibb SAB / SLG
L IPCI Orencia4 Fertigspritze(n)945.541044.7510 %Injektionslösung zur subkutanen Anwendung (Fertigspritze mit Nadelschutz): Abataceptum 125 mg/mlBristol-Myers Squibb SAB / SLG
LSIPIP  Orencia 250 mgDurchstechflasche(n)344.08390.6010 %Pulver zur Herstellung eines Infusionslösungkonzentrats: Abataceptum 250 mgBristol-Myers Squibb SAA / SLG
Fingolimod (L04AA27) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Fingolimod Viatris 0,5 mg28380.52430.2510 %Capsules: FingolimodumViatris Pharma GmbH● B / SL / SGG
L IPCI Fingolimod Viatris 0,5 mg981331.831464.8510 %Capsules: FingolimodumViatris Pharma GmbHB / SL / SGG
Belatacept (L04AA28) 2 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IP  Nulojix 250 mg 288.58330.2510 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mgBristol-Myers Squibb SAA / SLG
L IP  Nulojix 250 mg2577.16644.1010 %Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Belataceptum 250 mgBristol-Myers Squibb SAA / SLG
Apremilast (L04AA32) 19 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Otezla 30mg56 Tablet(s)292.31334.8510 %Coated tablets: Apremilastum 30 mgAmgen Switzerland AGB / SL / SOG
L IPCI Otezla 10 mg, 20 mg19 Tablet(s)138.01166.7510 %mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg		Amgen Switzerland AGB / SL / SOG
L IPCI Apremilast Leman 30 mg56240.00281.1510 %Coated tablets: Apremilastum 30 mgLeman SKL SAB / SL / SGG
L IPCI Apremilast Spirig HC 30 mg56280.98323.2010 %Coated tablets: Apremilastum 30 mgSpirig HealthCare AGB / SL / SGG
L IPCI Apremilast Spirig HC 30 mg168716.49795.6510 %Coated tablets: Apremilastum 30 mgSpirig HealthCare AGB / SL / SGG
L IPCI Apremilast Spirig HC 10 mg / 20 mg / 30 mg4 + 19132.97161.6010 %Coated tablets: Apremilastum 10 mg
Coated tablets: Apremilastum 20 mg
Coated tablets: Apremilastum 30 mg		Spirig HealthCare AGB / SL / SGG
L IPCI Apremilast-Mepha 30 mg56280.98323.2010 %Coated tablets: Apremilastum 30 mgMepha Pharma AGB / SL / SGG
L IPCI Apremilast Leman 10 mg, 20 mg4 + 19113.00141.1010 %mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg		Leman SKL SAB / SL / SGG
L IPCI Apremilast-Mepha 10 mg, 20 mg4 + 19132.97161.6010 %mg Filmtabletten: Apremilastum 10 mg
mg Filmtabletten: Apremilastum 20 mg
mg Filmtabletten: Apremilastum 30 mg		Mepha Pharma AGB / SL / SGG
  IPCI Apremilast Leman k.A.Leman SKL SAG
  IPCI Apremilast Accord 30 mg56k.A.Coated tablets: Apremilastum 30 mgAccord Healthcare AGBG
  IPCI Apremilast Accord 10 mg, 20 mg4 + 19k.A.mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg		Accord Healthcare AGBG
L IPCI Apremilast Devatis 30 mg56280.98323.2010 %Coated tablets: Apremilastum 30 mgDevatis AGB / SL / SGG
L IPCI Apremilast Devatis 10 mg, 20 mg4 + 19132.97161.6010 %mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg		Devatis AGB / SL / SGG
  IPCI Apremilast Leman 30 mg168k.A.Coated tablets: Apremilastum 30 mgLeman SKL SABG
     Apremilast Sandoz 30 mg56k.A.Coated tablets: Apremilastum 30 mgSandoz
Pharmaceuticals AG		BG
     Apremilast Sandoz eco 30 mg56k.A.Coated tablets: Apremilastum 30 mgSandoz
Pharmaceuticals AG		BG
     Apremilast Sandoz eco 10 mg / 20 mg / 30 mg4 + 19k.A.Coated tablets: Apremilastum 10 mg
Coated tablets: Apremilastum 20 mg
Coated tablets: Apremilastum 30 mg		Sandoz
Pharmaceuticals AG		BG
     Apremilast Sandoz 10 mg, 20 mg4 + 19k.A.mg: Apremilastum 10 mg
mg: Apremilastum 20 mg
mg: Apremilastum 30 mg		Sandoz
Pharmaceuticals AG		BG
Alemtuzumab (L04AA34) 1 products WHO-DDD DrugBank.ca
Page 1 of 2: 12>>
L IPCI Lemtrada 10 mg/mlDurchstechflasche(n)6740.577223.6010 %Concentrate for infusion: Alemtuzumabum 12mg / 1.2mlSanofi-Aventis
(Suisse) SA		● A / SLG
Baricitinib (L04AA37) 2 products WHO-DDD 
Page 1 of 2: 12>>
L IPCIPPOlumiant 2 mg28871.24963.9510 %Coated tablets: Baricitinibum 2 mgEli Lilly (Suisse) SAB / SLG
L IPCIPPOlumiant 4 mg28871.24963.9510 %Coated tablets: Baricitinibum 4 mgEli Lilly (Suisse) SAB / SLG
Cladribine (L04AA40) 3 products WHO-DDD 
Page 1 of 2: 12>>
L IPCI Mavenclad 10 mg 2348.192570.2010 %Tablets: Cladribinum 10 mgMerck (Schweiz) AGA / SLG
L IPCI Mavenclad 10 mg49392.769944.7510 %Tablets: Cladribinum 10 mgMerck (Schweiz) AGA / SLG
L IPCI Mavenclad 10 mg614089.1414763.2510 %Tablets: Cladribinum 10 mgMerck (Schweiz) AGA / SLG
Imlifidase (L04AA41) 2 products WHO-DDD 
Page 1 of 2: 12>>
L IP  Idefirix 11 mg + + 137798.05141688.6010 %poudre pour solution à diluer pour perfusion: Imlifidasum 11 mgiQone Healthcare
Switzerland SA		A / SLG
  IP  Idefirix 11 mg2k.A.poudre pour solution à diluer pour perfusion: Imlifidasum 11 mgiQone Healthcare
Switzerland SA		AG
Inebilizumab (L04AA47) 1 products WHO-DDD 
Page 1 of 2: 12>>
  IP  Uplizna 100 mg/10ml3k.A.Concentrate for infusion: Inebilizumabum 100mg / 10mlAmgen Switzerland AGAG
Ponesimod (L04AA50) 5 products WHO-DDD 
Page 1 of 2: 12>>
L IPCI Ponvory 20 mg28973.281074.9010 %Coated tablets: Ponesimodum 20 mgMedius AGB / SLG
  IPCI Ponvory 3 mg k.A.Coated tablets: Ponesimodum 3 mgMedius AGBG
  IPCI Ponvory 5 mg k.A.Coated tablets: Ponesimodum 5 mgMedius AGBG
  IPCI Ponvory 7 mg k.A.Coated tablets: Ponesimodum 7 mgMedius AGBG
  IPCI Ponvory 9 mg k.A.Coated tablets: Ponesimodum 9 mgMedius AGBG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home